| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 58 |
| Sex | Both Genders |
| Age Range | 45-64, 65+ |
| Body Types | Overweight |
A reduction in tenderness and swelling of joints was detected in persons with Rheumatoid arthritis associated with 300mg of a 30% Andrographolide supplement over 14 weeks.
